[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Market - Global Outlook and Forecast 2021-2027

April 2021 | 107 pages | ID: E81C95134A7CEN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) in global, including the following market information:

Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Market Sales, 2016-2021, 2022-2027, (K Units)

Global top five Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) companies in 2020 (%)

The global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)

Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Market Segment Percentages, By Type, 2020 (%)
  • 60 KIU
  • 50 KIU
Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)

Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Market Segment Percentages, By Application, 2020 (%)
  • Bleeding
  • Surgery Assisted
  • Glanzmann Plateletasthenia
  • Hemophilia B
  • Hemophilia A
  • Head Trauma
  • Others
Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Units)

Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) revenues in global market, 2016-2021 (Estimated), ($ millions)

Key companies Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) revenues share in global market, 2020 (%)

Key companies Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) sales in global market, 2016-2021 (Estimated), (K Units)

Key companies Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) sales share in global market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • BMS
  • Generium
  • Novo Nordisk
  • Shire (Baxter)
  • Bayer
  • CSL
  • Pfizer
  • Grifols
  • Biogen
  • Octapharma
  • NovoNordisk
  • Greencross
  • Kedrion
  • BPL
  • Hualan Bio
  • RAAS
  • Suzhou Alphamab
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL EPTACOG ALFA (RECOMBINANT HUMAN COAGULATION FACTOR VIIA) OVERALL MARKET SIZE

2.1 Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Market Size: 2021 VS 2027
2.2 Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales (Consumption): 2016-2027

3 COMPANY LANDSCAPE

3.1 Top Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Players in Global Market
3.2 Top Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Companies Ranked by Revenue
3.3 Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue by Companies
3.4 Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales by Companies
3.5 Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Players in Global Market
  3.8.1 List of Global Tier 1 Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Companies
  3.8.2 List of Global Tier 2 and Tier 3 Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Market Size Markets, 2021 & 2027
  4.1.2 60 KIU
  4.1.3 50 KIU
4.2 By Type - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue & Forecasts
  4.2.1 By Type - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue, 2016-2021
  4.2.2 By Type - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue, 2022-2027
  4.2.3 By Type - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue Market Share, 2016-2027
4.3 By Type - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales & Forecasts
  4.3.1 By Type - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales, 2016-2021
  4.3.2 By Type - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales, 2022-2027
  4.3.3 By Type - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales Market Share, 2016-2027
4.4 By Type - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Price (Manufacturers Selling Prices), 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Market Size, 2021 & 2027
  5.1.2 Bleeding
  5.1.3 Surgery Assisted
  5.1.4 Glanzmann Plateletasthenia
  5.1.5 Hemophilia B
  5.1.6 Hemophilia A
  5.1.7 Head Trauma
  5.1.8 Others
5.2 By Application - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue & Forecasts
  5.2.1 By Application - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue, 2016-2021
  5.2.2 By Application - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue, 2022-2027
  5.2.3 By Application - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue Market Share, 2016-2027
5.3 By Application - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales & Forecasts
  5.3.1 By Application - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales, 2016-2021
  5.3.2 By Application - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales, 2022-2027
  5.3.3 By Application - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales Market Share, 2016-2027
5.4 By Application - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Price (Manufacturers Selling Prices), 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Market Size, 2021 & 2027
6.2 By Region - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue & Forecasts
  6.2.1 By Region - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue, 2016-2021
  6.2.2 By Region - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue, 2022-2027
  6.2.3 By Region - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue Market Share, 2016-2027
6.3 By Region - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales & Forecasts
  6.3.1 By Region - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales, 2016-2021
  6.3.2 By Region - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales, 2022-2027
  6.3.3 By Region - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales Market Share, 2016-2027
6.4 North America
  6.4.1 By Country - North America Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue, 2016-2027
  6.4.2 By Country - North America Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales, 2016-2027
  6.4.3 US Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Market Size, 2016-2027
  6.4.4 Canada Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Market Size, 2016-2027
  6.4.5 Mexico Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Market Size, 2016-2027
6.5 Europe
  6.5.1 By Country - Europe Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue, 2016-2027
  6.5.2 By Country - Europe Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales, 2016-2027
  6.5.3 Germany Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Market Size, 2016-2027
  6.5.4 France Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Market Size, 2016-2027
  6.5.5 U.K. Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Market Size, 2016-2027
  6.5.6 Italy Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Market Size, 2016-2027
  6.5.7 Russia Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Market Size, 2016-2027
  6.5.8 Nordic Countries Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Market Size, 2016-2027
  6.5.9 Benelux Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Market Size, 2016-2027
6.6 Asia
  6.6.1 By Region - Asia Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue, 2016-2027
  6.6.2 By Region - Asia Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales, 2016-2027
  6.6.3 China Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Market Size, 2016-2027
  6.6.4 Japan Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Market Size, 2016-2027
  6.6.5 South Korea Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Market Size, 2016-2027
  6.6.6 Southeast Asia Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Market Size, 2016-2027
  6.6.7 India Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Market Size, 2016-2027
6.7 South America
  6.7.1 By Country - South America Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue, 2016-2027
  6.7.2 By Country - South America Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales, 2016-2027
  6.7.3 Brazil Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Market Size, 2016-2027
  6.7.4 Argentina Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Market Size, 2016-2027
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue, 2016-2027
  6.8.2 By Country - Middle East & Africa Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales, 2016-2027
  6.8.3 Turkey Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Market Size, 2016-2027
  6.8.4 Israel Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Market Size, 2016-2027
  6.8.5 Saudi Arabia Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Market Size, 2016-2027
  6.8.6 UAE Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Market Size, 2016-2027

7 MANUFACTURERS & BRANDS PROFILES

7.1 BMS
  7.1.1 BMS Corporate Summary
  7.1.2 BMS Business Overview
  7.1.3 BMS Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Major Product Offerings
  7.1.4 BMS Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales and Revenue in Global (2016-2021)
  7.1.5 BMS Key News
7.2 Generium
  7.2.1 Generium Corporate Summary
  7.2.2 Generium Business Overview
  7.2.3 Generium Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Major Product Offerings
  7.2.4 Generium Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales and Revenue in Global (2016-2021)
  7.2.5 Generium Key News
7.3 Novo Nordisk
  7.3.1 Novo Nordisk Corporate Summary
  7.3.2 Novo Nordisk Business Overview
  7.3.3 Novo Nordisk Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Major Product Offerings
  7.3.4 Novo Nordisk Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales and Revenue in Global (2016-2021)
  7.3.5 Novo Nordisk Key News
7.4 Shire (Baxter)
  7.4.1 Shire (Baxter) Corporate Summary
  7.4.2 Shire (Baxter) Business Overview
  7.4.3 Shire (Baxter) Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Major Product Offerings
  7.4.4 Shire (Baxter) Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales and Revenue in Global (2016-2021)
  7.4.5 Shire (Baxter) Key News
7.5 Bayer
  7.5.1 Bayer Corporate Summary
  7.5.2 Bayer Business Overview
  7.5.3 Bayer Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Major Product Offerings
  7.5.4 Bayer Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales and Revenue in Global (2016-2021)
  7.5.5 Bayer Key News
7.6 CSL
  7.6.1 CSL Corporate Summary
  7.6.2 CSL Business Overview
  7.6.3 CSL Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Major Product Offerings
  7.6.4 CSL Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales and Revenue in Global (2016-2021)
  7.6.5 CSL Key News
7.7 Pfizer
  7.7.1 Pfizer Corporate Summary
  7.7.2 Pfizer Business Overview
  7.7.3 Pfizer Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Major Product Offerings
  7.4.4 Pfizer Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales and Revenue in Global (2016-2021)
  7.7.5 Pfizer Key News
7.8 Grifols
  7.8.1 Grifols Corporate Summary
  7.8.2 Grifols Business Overview
  7.8.3 Grifols Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Major Product Offerings
  7.8.4 Grifols Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales and Revenue in Global (2016-2021)
  7.8.5 Grifols Key News
7.9 Biogen
  7.9.1 Biogen Corporate Summary
  7.9.2 Biogen Business Overview
  7.9.3 Biogen Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Major Product Offerings
  7.9.4 Biogen Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales and Revenue in Global (2016-2021)
  7.9.5 Biogen Key News
7.10 Octapharma
  7.10.1 Octapharma Corporate Summary
  7.10.2 Octapharma Business Overview
  7.10.3 Octapharma Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Major Product Offerings
  7.10.4 Octapharma Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales and Revenue in Global (2016-2021)
  7.10.5 Octapharma Key News
7.11 NovoNordisk
  7.11.1 NovoNordisk Corporate Summary
  7.11.2 NovoNordisk Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Business Overview
  7.11.3 NovoNordisk Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Major Product Offerings
  7.11.4 NovoNordisk Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales and Revenue in Global (2016-2021)
  7.11.5 NovoNordisk Key News
7.12 Greencross
  7.12.1 Greencross Corporate Summary
  7.12.2 Greencross Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Business Overview
  7.12.3 Greencross Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Major Product Offerings
  7.12.4 Greencross Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales and Revenue in Global (2016-2021)
  7.12.5 Greencross Key News
7.13 Kedrion
  7.13.1 Kedrion Corporate Summary
  7.13.2 Kedrion Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Business Overview
  7.13.3 Kedrion Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Major Product Offerings
  7.13.4 Kedrion Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales and Revenue in Global (2016-2021)
  7.13.5 Kedrion Key News
7.14 BPL
  7.14.1 BPL Corporate Summary
  7.14.2 BPL Business Overview
  7.14.3 BPL Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Major Product Offerings
  7.14.4 BPL Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales and Revenue in Global (2016-2021)
  7.14.5 BPL Key News
7.15 Hualan Bio
  7.15.1 Hualan Bio Corporate Summary
  7.15.2 Hualan Bio Business Overview
  7.15.3 Hualan Bio Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Major Product Offerings
  7.15.4 Hualan Bio Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales and Revenue in Global (2016-2021)
  7.15.5 Hualan Bio Key News
7.16 RAAS
  7.16.1 RAAS Corporate Summary
  7.16.2 RAAS Business Overview
  7.16.3 RAAS Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Major Product Offerings
  7.16.4 RAAS Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales and Revenue in Global (2016-2021)
  7.16.5 RAAS Key News
7.17 Suzhou Alphamab
  7.17.1 Suzhou Alphamab Corporate Summary
  7.17.2 Suzhou Alphamab Business Overview
  7.17.3 Suzhou Alphamab Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Major Product Offerings
  7.17.4 Suzhou Alphamab Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales and Revenue in Global (2016-2021)
  7.17.5 Suzhou Alphamab Key News

8 GLOBAL EPTACOG ALFA (RECOMBINANT HUMAN COAGULATION FACTOR VIIA) PRODUCTION CAPACITY, ANALYSIS

8.1 Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Production Capacity, 2016-2027
8.2 Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Production Capacity of Key Manufacturers in Global Market
8.3 Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 EPTACOG ALFA (RECOMBINANT HUMAN COAGULATION FACTOR VIIA) SUPPLY CHAIN ANALYSIS

10.1 Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Industry Value Chain
10.2 Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Upstream Market
10.3 Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES

Table 1. Key Players of Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) in Global Market
Table 2. Top Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue Share by Companies, 2016-2021
Table 5. Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales by Companies, (K Units), 2016-2021
Table 6. Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Price (2016-2021) & (US$/Unit)
Table 8. Global Manufacturers Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Product Type
Table 9. List of Global Tier 1 Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales (K Units), 2016-2021
Table 15. By Type - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales (K Units), 2022-2027
Table 16. By Application – Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales (K Units), 2016-2021
Table 20. By Application - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales (K Units), 2022-2027
Table 21. By Region – Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales (K Units), 2016-2021
Table 25. By Region - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales (K Units), 2022-2027
Table 26. By Country - North America Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales, (K Units), 2016-2021
Table 29. By Country - North America Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales, (K Units), 2022-2027
Table 30. By Country - Europe Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales, (K Units), 2016-2021
Table 33. By Country - Europe Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales, (K Units), 2022-2027
Table 34. By Region - Asia Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales, (K Units), 2016-2021
Table 37. By Region - Asia Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales, (K Units), 2022-2027
Table 38. By Country - South America Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales, (K Units), 2016-2021
Table 41. By Country - South America Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales, (K Units), 2022-2027
Table 42. By Country - Middle East & Africa Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales, (K Units), 2016-2021
Table 45. By Country - Middle East & Africa Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales, (K Units), 2022-2027
Table 46. BMS Corporate Summary
Table 47. BMS Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Product Offerings
Table 48. BMS Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 49. Generium Corporate Summary
Table 50. Generium Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Product Offerings
Table 51. Generium Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 52. Novo Nordisk Corporate Summary
Table 53. Novo Nordisk Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Product Offerings
Table 54. Novo Nordisk Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 55. Shire (Baxter) Corporate Summary
Table 56. Shire (Baxter) Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Product Offerings
Table 57. Shire (Baxter) Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 58. Bayer Corporate Summary
Table 59. Bayer Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Product Offerings
Table 60. Bayer Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 61. CSL Corporate Summary
Table 62. CSL Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Product Offerings
Table 63. CSL Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 64. Pfizer Corporate Summary
Table 65. Pfizer Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Product Offerings
Table 66. Pfizer Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 67. Grifols Corporate Summary
Table 68. Grifols Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Product Offerings
Table 69. Grifols Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 70. Biogen Corporate Summary
Table 71. Biogen Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Product Offerings
Table 72. Biogen Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 73. Octapharma Corporate Summary
Table 74. Octapharma Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Product Offerings
Table 75. Octapharma Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 76. NovoNordisk Corporate Summary
Table 77. NovoNordisk Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Product Offerings
Table 78. NovoNordisk Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 79. Greencross Corporate Summary
Table 80. Greencross Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Product Offerings
Table 81. Greencross Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 82. Kedrion Corporate Summary
Table 83. Kedrion Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Product Offerings
Table 84. Kedrion Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 85. BPL Corporate Summary
Table 86. BPL Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Product Offerings
Table 87. BPL Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 88. Hualan Bio Corporate Summary
Table 89. Hualan Bio Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Product Offerings
Table 90. Hualan Bio Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 91. RAAS Corporate Summary
Table 92. RAAS Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Product Offerings
Table 93. RAAS Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 94. Suzhou Alphamab Corporate Summary
Table 95. Suzhou Alphamab Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Product Offerings
Table 96. Suzhou Alphamab Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 97. Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Production Capacity (K Units) of Key Manufacturers in Global Market, 2019-2021 (K Units)
Table 98. Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Capacity Market Share of Key Manufacturers, 2019-2021
Table 99. Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Production by Region, 2016-2021 (K Units)
Table 100. Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Production by Region, 2022-2027 (K Units)
Table 101. Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Market Opportunities & Trends in Global Market
Table 102. Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Market Drivers in Global Market
Table 103. Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Market Restraints in Global Market
Table 104. Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Raw Materials
Table 105. Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Raw Materials Suppliers in Global Market
Table 106. Typical Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Downstream
Table 107. Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Downstream Clients in Global Market
Table 108. Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Distributors and Sales Agents in Global Market

LIST OF FIGURES

Figure 1. Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Segment by Type
Figure 2. Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Segment by Application
Figure 3. Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue, 2016-2027 (US$, Mn)
Figure 7. Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales in Global Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue in 2020
Figure 9. By Type - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales Market Share, 2016-2027
Figure 10. By Type - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue Market Share, 2016-2027
Figure 11. By Type - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Price (US$/Unit), 2016-2027
Figure 12. By Application - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales Market Share, 2016-2027
Figure 13. By Application - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue Market Share, 2016-2027
Figure 14. By Application - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Price (US$/Unit), 2016-2027
Figure 15. By Region - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales Market Share, 2016-2027
Figure 16. By Region - Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue Market Share, 2016-2027
Figure 17. By Country - North America Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue Market Share, 2016-2027
Figure 18. By Country - North America Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales Market Share, 2016-2027
Figure 19. US Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales Market Share, 2016-2027
Figure 24. Germany Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue, (US$, Mn), 2016-2027
Figure 25. France Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales Market Share, 2016-2027
Figure 33. China Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue, (US$, Mn), 2016-2027
Figure 37. India Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue Market Share, 2016-2027
Figure 39. By Country - South America Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales Market Share, 2016-2027
Figure 40. Brazil Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Sales Market Share, 2016-2027
Figure 44. Turkey Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Revenue, (US$, Mn), 2016-2027
Figure 48. Global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Production Capacity (K Units), 2016-2027
Figure 49. The Percentage of Production Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) by Region, 2020 VS 2027
Figure 50. Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) Industry Value Chain
Figure 51. Marketing Channels


More Publications